{"schema":"rootz.ai/sec-company/v1","layer":1,"cik":"0001661059","name":"NextCure, Inc.","summary":"NextCure, Inc. is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) for cancer patients who do not respond to current therapies. Its lead candidates include SIM0505, a CDH6-targeted ADC licensed from Simcere Zaiming with a proprietary TOPOi payload, and LNCB74, a B7-H4-targeted ADC developed with LigaChem Biosciences using an MMAE tubulin inhibitor payload, targeting solid tumors including ovarian, breast, and endometrial cancers.","people":[],"products":[{"name":"SIM0505","type":"platform","description":"Novel ADC targeting CDH6 with a proprietary TOPO1 inhibitor payload (CPT116, DAR 8) for solid tumors including ovarian, endometrial, NSCLC, and renal cancers."},{"name":"LNCB74","type":"platform","description":"B7-H4-targeted ADC with MMAE payload (DAR 4) and glucuronidase-cleavable linker for breast, ovarian, and endometrial cancers, co-developed with LigaChem Biosciences."},{"name":"NC410","type":"platform","description":"Clinical oncology program being pursued for partnering or licensing."},{"name":"NC525","type":"platform","description":"Clinical oncology program being pursued for partnering or licensing."},{"name":"NC181","type":"platform","description":"Humanized antibody targeting ApoE4 for Alzheimer's disease treatment; preclinical non-oncology program seeking partner or third-party financing."},{"name":"NC605","type":"platform","description":"Antibody targeting Siglec-15 for treatment of osteogenesis imperfecta; preclinical non-oncology program seeking partner or third-party financing."}],"partnerships":[{"partner_name":"Simcere Zaiming Pharmaceutical Co., Ltd.","partnership_type":"licensing","description":"Exclusive worldwide license (excluding Zaiming Territory) to develop, manufacture, and commercialize SIM0505 and related ADC compounds; Zaiming retains rights in China, Hong Kong, Macau, and Taiwan.","start_date":null},{"partner_name":"LigaChem Biosciences, Inc.","partnership_type":"development","description":"Research Collaboration and Co-Development Agreement (November 2022) for LNCB74; both parties equally share development costs and profits.","start_date":null}],"affiliations":[],"origin":{"leaf":"bca29043d88261bcb5f0bbfd6a804151bacb0cb2ccc955946da57cae51db8c08","formula":"v2: sha256( sha256(content) || parent || source_accession )","content_sha256":"be58f39955e83b4f97990db6c8639332f746e732f670a771790807e6ab6f1f18","parent":"fe6205118741098dd30df9c19c33c4949a73dd117c599523b169c7a19d3e74b7","source":"0001104659-26-024137","chain":"sec.gov/EDGAR (retrieved over TLS, accession recorded) > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Recompute it: sha256(sha256(<this response body minus the origin block>) || parent || source_accession). Deterministic — the same record yields the same leaf every time. GET /api/verify/{leaf} tells you whether we issued it.","stronger_check":"The leaf is our own hash. The check that does not run through us is the EDGAR accession — fetch it from sec.gov and compare.","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin leaf (see origin.leaf). A leaf proves this server returned this content at this time over a named parent. It does NOT prove that a model extracted a filing correctly.","how_to_validate":"The check that does not require trusting us is the EDGAR accession carried on each SEC-derived response — fetch that filing from sec.gov and compare. GET https://origin.rootz.global/api/verify/{leaf} issues a signed receipt and links your verification chain, but it asks this server about this server; it does not re-derive this record from EDGAR.","chain":"SEC.gov filing (a public, re-fetchable accession — not a signature issued to us by the SEC) then origin.rootz.global extraction then this response.","licensing":"Reading is free. For commercial/high-volume use, register a key documented at origin.rootz.global/dashboard. Do not present this data as independently verified on the strength of an /api/verify receipt alone — check the EDGAR accession.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":500,"hourly_limit":500,"remaining":0,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"Check the EDGAR accession on this record against sec.gov — that check does not run through us. Response signature and the exact rule: https://origin.rootz.global/verify","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}